Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-005562
Filing Date
2021-11-15
Accepted
2021-11-15 08:00:58
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sonoma_i10q-093021.htm   iXBRL 10-Q 1012800
2 CERTIFICATION sonoma_ex3101.htm EX-31.1 8545
3 CERTIFICATION sonoma_ex3102.htm EX-31.2 8367
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4918
  Complete submission text file 0001683168-21-005562.txt   4982479

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20210930.xsd EX-101.SCH 32178
6 XBRL CALCULATION FILE snoa-20210930_cal.xml EX-101.CAL 60704
7 XBRL DEFINITION FILE snoa-20210930_def.xml EX-101.DEF 142183
8 XBRL LABEL FILE snoa-20210930_lab.xml EX-101.LAB 310852
9 XBRL PRESENTATION FILE snoa-20210930_pre.xml EX-101.PRE 255821
10 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-093021_htm.xml XML 794972
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 211406442
SIC: 2834 Pharmaceutical Preparations